Related Experiment Video
Updated: Jun 10, 2026
06:06
High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
Published on: December 20, 2024
p16INK4a expression in basal-like breast carcinoma
Olga L Bohn1, Mariana Fuertes-Camilo, Leticia Navarro
1Department of Pathology, MetroHealth Medical Center-Case Western Reserve University, Cleveland, OH 44109, USA. olga.bohn@gmail.com
Summary
p16(INK4a) is strongly expressed in basal-like breast cancer (BLBC), a type of invasive carcinoma linked to poor outcomes. This suggests p16(INK4a) may contribute to the aggressive behavior and poor prognosis observed in BLBC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Basal-like breast cancer (BLBC) is a distinct invasive carcinoma subtype characterized by a specific immunoprofile and associated with poor patient outcomes.
- BLBCs are typically estrogen receptor (ER)-negative, progesterone receptor (PgR)-negative, and HER2-negative, often expressing basal cytokeratins (CKs), EGFR, and CD117.
- The p16(INK4a) protein, encoded by the CDKN2A gene, is a cell cycle regulator implicated in various malignancies.
Purpose of the Study:
- To investigate the expression of the tumor suppressor protein p16(INK4a) in basal-like breast cancer (BLBC).
- To compare p16(INK4a) expression in BLBC with high-grade invasive carcinoma (HG-IC) of the breast.
- To explore the potential role of p16(INK4a) in the aggressive behavior and poor prognosis of BLBC.
Main Methods:
- Tissue microarrays (TMA) were constructed in triplicate, including samples from 18 BLBC cases and 18 HG-IC cases.
- Immunohistochemical analysis was performed to assess the expression of p16(INK4a), along with ER, PgR, HER2, basal cytokeratins (CK 5/6, CK 14), EGFR, and CD117.
Main Results:
- All 18 BLBC cases analyzed were confirmed to be ER-/PgR-/HER2-.
- The majority of BLBC cases exhibited a basal-like immunophenotype: 94% were positive for CK 5/6 and CK 14, 78% showed EGFR expression, and 72% were CD117 positive.
- Strong positive p16(INK4a) expression was observed in 89% (16 out of 18) of BLBC cases, compared to unspecified results for HG-IC.
Conclusions:
- p16(INK4a) is significantly and strongly expressed in breast cancers exhibiting a basal-like phenotype.
- The high expression of p16(INK4a) in BLBC, coupled with its known association with aggressive behavior in other carcinomas, suggests a potential role in the poor prognosis of BLBC.
- Further research is warranted to fully elucidate the functional significance of p16(INK4a) in the pathogenesis and progression of basal-like breast cancer.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...